Provenance du réseau au premier degré de Cameron Myhrvold
Entité | Type d'entité | Industrie | |
---|---|---|---|
Carver Biosciences, Inc.
Carver Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Carver Biosciences, Inc. is a gene therapy company based in Dedham, MA. Carver is developing CRISPR-based therapies for RNA viruses that infect humans, using a programmable platform technology that could offer a generalizable solution for treating many viruses. The company's underlying technology was developed by co-founder Dr. Cameron Myhrvold. Carver Biosciences is leveraging Cas13 to target respiratory viruses at the RNA level, with the aim of destroying the viruses and preventing them from replicating. The company's therapeutics would act in concert with Dr. Uri Lopatin. The company was founded by Cameron Myhrvold and Walter Strapps, with Walter Strapps serving as the CEO since incorporation.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Cameron Myhrvold via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
INTELLIA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
McGill University | College/University | Undergraduate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Columbia University Vagelos College of Physicians & Surgeons | College/University | Doctorate Degree | |
SONA NANOTECH INC. | Chemicals: Specialty | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 5 |
Canada | 3 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Process Industries | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Director/Board Member | 1 |
Relations les plus connectées
Insiders | |
---|---|
Walter Strapps | 7 |
- Bourse
- Insiders
- Cameron Myhrvold
- Connexions Sociétés